| Model: | Ratio |
| Symbol | Title | Sector | Industry | M.Cap.[M] | Div Yield | Last Close | AvgVol 200d |
| TSHA | Taysha Gene Therapies Inc | Healthcare | Biotechnology | 1169 | 4.07 | 4013339 | |
| ABSI | Absci Corp | Healthcare | Biotechnology | 425 | 2.76 | 4625378 |
| Entry Threshold: | 2.00 | Exit Threshold: | 0.00 | ||
| Max Duration: | 20 | Entry Mode: | Uptick | Reversals: | |
| MA Period: | 15 | MA Type: | EMA | StdDev Period: | 15 |
| RSI Period: | 14 | RSI Threshold: | 0 | ||
| Margin Req. 1: | 50.0 | Margin Req. 2: | 50.0 | ||
| Version: | 5 | Model Version: | 2016.1 | Bid-Ask 0.01 / 0.01 | |
| Initial Capital: | 10000.00 | Final Equity: | -20943.16 |
| Total net P/L: | -30943.16 | Total ROI: | -309.43 % |
| CAGR: | 0.00 % | Max. DD: | 220.04 % |
| System Score: | 0.000 | Sharpe Ratio: | -0.290 |
| Start Date: | 2021-09-29 | End Date: | 2026-02-27 |
| Total days: | 1612 | ||
| Commissions: | 2522.61 | Comm.% P/L | 8.88 % |
| Total Transactions: | 100 | Log. Linearity: | 71.729 % |
| Total | Long |
Short |
TSHA | ABSI | |
|---|---|---|---|---|---|
| Total Profit/Loss | -28420.55 | -3163.95 | -25256.60 | -34612.41 | 6191.85 |
| Total Profit | 23556.39 | 9397.74 | 14158.65 | 21348.62 | 23780.12 |
| Total Loss | 51976.94 | 12561.69 | 39415.25 | 55961.03 | 17588.26 |
| Profit Factor | 0.45 | 0.75 | 0.36 | 0.38 | 1.35 |
| Trades | 25 | 12 | 13 | 25 | 25 |
| Winning Trades | 17 | 7 | 10 | 15 | 14 |
| Losing Trades | 8 | 5 | 3 | 10 | 11 |
| % Profitable | 68.00 | 58.00 | 76.00 | 60.00 | 56.00 |
| Profit/Loss Per Trade % | 0.00 | -2.61 | 0.00 | 0.00 | 0.58 |
| Profit Per Trade % | 11.82 | 10.95 | 12.43 | 12.36 | 13.62 |
| Loss Per Trade % | 30.22 | 17.51 | 54.55 | 27.70 | 13.03 |
| Days In Trade | 334 | 184 | 150 | 334 | 334 |
| Days In Trade (Avg. Per Trade) | 13.36 | 15.33 | 11.54 | 13.36 | 13.36 |
| % Days In Trade | 20.72 | 11.41 | 9.31 | 20.72 | 20.72 |